{"id":"W2607127088","doi":"10.1111/ijcp.12944","title":"Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)","year":2017,"lang":"en","type":"article","venue":"International Journal of Clinical Practice","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Astellas Pharma Europe; Astellas Pharma Global Development; Astellas Pharma","keywords":"Medicine; Mirabegron; Solifenacin; Overactive bladder; Urology; Refractory (planetary science); Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004527785,0.0001774699,0.0006346437,0.00024781,0.0001050395,0.0001311909,0.0005021989,0.0001233891,0.0001652935],"category_scores_gemma":[0.01812323,0.0001246551,0.00036695,0.00006713974,0.00008858916,0.001197327,0.0001249207,0.001470024,0.00004953832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002144002,"about_ca_system_score_gemma":0.00046025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001799166,"about_ca_topic_score_gemma":0.00002085604,"domain_scores_codex":[0.9956253,0.0005942349,0.001172432,0.0003110799,0.002054753,0.0002422384],"domain_scores_gemma":[0.9929686,0.002829717,0.001088795,0.0005204501,0.002280665,0.0003117284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1145588,0.005155753,0.4278001,0.00001363276,0.005290407,0.002961969,0.0006167986,0.0001830845,0.00005344092,0.00003429458,0.002763587,0.4405681],"study_design_scores_gemma":[0.009766018,0.003547213,0.7392123,0.0003554749,0.00008743098,0.0001239147,0.0001050692,0.00001383357,0.00008913813,0.00003744679,0.2465467,0.0001154279],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9626931,0.0003207438,0.000284899,0.01730127,0.00121988,0.0005079536,0.00001445952,0.000007244179,0.01765044],"genre_scores_gemma":[0.9927098,0.002072576,0.001655025,0.002114881,0.001144575,0.000005189325,0.000007065221,0.00002922346,0.0002617295],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4404527,"threshold_uncertainty_score":0.9901475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06868613109689006,"score_gpt":0.4578434500291966,"score_spread":0.3891573189323065,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}